Elsevier

Atherosclerosis

Volume 108, Issue 1, July 1994, Pages 61-72
Atherosclerosis

Research paper
Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage—foam cell accumulation independently of blood pressure and plasma lipids

https://doi.org/10.1016/0021-9150(94)90037-XGet rights and content

Abstract

The effect of two angiotensin converting enzyme (ACE) inhibitors on the development of atherosclerosis was determined in hyperlipidemic hamsters. Preliminary studies indicated that only fosinopril (50 mg/kg) temporarily decreased mean arterial pressure, while after chronic dosing fosinopril and captopril (50 mg/kg) were ineffective. The same dose of fosinopril and captopril inhibited the angiotensin I pressor response, indicating these agents suppressed ACE activity in vivo. In the 3 week atherosclerosis experiment, all hamsters were fed chow supplemented with 0.05% cholesterol and 10% coconut oil. Control hamsters were compared with those receiving either 50 mg/kg per day of fosinopril or 50 mg/kg per day of captopril. After 3 weeks, fosinopril reduced plasma total cholesterol, low density lipoprotein (LDL) plus very low density lipoprotein cholesterol and total triglycerides by 17%, 27% and 45%, respectively. Captopril only reduced high density lipoprotein cholesterol by 20%. Neither fosinopril or captopril altered blood pressure at 3 weeks. Atherosclerosis was quantified from en face preparations of the lesion-prone aortic arch that were stained with oil red O (for cholesteryl ester and triglycerides). In control hamsters, oil red O labeled numerous subendothelial macrophage-foam cells located along the inner curvature of the aortic arch. Compared with controls, fosinopril reduced the number of intimal macrophage-foam cells/mm2, foam cell size and the fatty streak area by 85%, 38% and 90%, respectively. Captopril decreased these parameters by 44%, 16% and 53%. Thus captopril decreased early atherosclerosis without affecting plasma LDL cholesterol or blood pressure, which suggested that inhibiting ACE (or kininase II) directly impeded the accumulation and formation of macrophage-foam cells. Fosinopril probably further suppressed early atherosclerosis by lowering plasma LDL cholesterol.

References (62)

  • A. Nistor et al.

    The hyperlipidemic hamster as a model of experimental atherosclerosis

    Atherosclerosis

    (1987)
  • R. Re et al.

    Renin synthesis by canine aortic smooth muscle cells in culture

    Life Sci.

    (1982)
  • U.S. Ryan et al.

    Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence

    Tissue Cell

    (1976)
  • E.J. Goetzl et al.

    The preferential human mononuclear leukocyte chemotactic activity of the substituent tetrapep tides of angiotensin II

    Biochem. Biophys. Res. Commun.

    (1980)
  • Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project

    J. Chron. Dis.

    (1978)
  • W.B. Robertson et al.

    Atherosclerosis in persons with hypertension and diabetes mellitus

    Lab. Invest.

    (1968)
  • L.A. Solberg et al.

    Stenoses in the coronary arteries. Relation to atherosclerotic lesions, coronary heart disease and risk factors. The Oslo study

    Lab. Invest.

    (1985)
  • L. Waters et al.

    A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis

    Circulation

    (1990)
  • N. Simionescu et al.

    Prelesional events of atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit

    Am. J. Pathol.

    (1986)
  • H.S. Kruth

    Localization of unesterified cholesterol in human atherosclerotic lesions. Demonstration of filipin-positive, oil-red-O-negative particles

    Am. J. Pathol.

    (1984)
  • G.L. Duff et al.

    The morphology of early atherosclerostic lesions of the aorta demonstrated by the surface technique in rabbits fed cho lesterol together with a description of the anatomy of the intima of the rabbit's aorta and the “spontaneous” lesions that occur in it

    Am. J. Pathol.

    (1957)
  • R.G. Gerrity et al.

    Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages

    Am. J. Pathol.

    (1979)
  • I. Joris et al.

    Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats

    Am. J. Pathol.

    (1983)
  • D. Steinberg et al.

    Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

    N. Eng. J. Med.

    (1989)
  • B.G.J. Salisbury et al.

    Insoluble low-density lipoprotein-proteoglycan complexes enhance cholesteryl ester accumulation in macrophages

    Am. J. Pathol.

    (1985)
  • J.C. Khoo et al.

    Enhanced macrophage uptake of low density lipoprotein after self-aggregation

    Arteriosclerosis

    (1988)
  • J.W. Heinecke et al.

    Phagocytosis of lipase-aggregated low density lipoprotein promotes macrophage foam cell formation. Sequential morphological and biochemical events

    Arteriosclerosis Thromb.

    (1991)
  • A. Faggiotto et al.

    Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation

    Arteriosclerosis

    (1984)
  • M.E. Rosenfeld et al.

    Fatty streak expansion and maturation in Watanabe Heritable Hyperlipidemic and comparably hypercholesterolemic fat-fed rabbits

    Arteriosclerosis

    (1987)
  • N.M. Aqel et al.

    Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies

    J. Pathol.

    (1985)
  • J. Masuda et al.

    Atherogenesis during low level hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque

    Arteriosclerosis

    (1990)
  • Cited by (98)

    • Evidence-Based Nutrition and Clinical Evidence of Bioactive Foods in Human Health and Disease

      2021, Evidence-Based Nutrition and Clinical Evidence of Bioactive Foods in Human Health and Disease
    • The renin-angiotensin system and its involvement in vascular disease

      2015, European Journal of Pharmacology
      Citation Excerpt :

      Because of the reported deleterious effects of Ang II on cardiovascular tissue, it seems logical to target the RAS and thereby reduce the development of cardiovascular damage. Several studies already demonstrated that ACE inhibitors might inhibit atherosclerosis in animal models independent of blood pressure lowering (Charpiot et al., 1993; Hayek et al., 1999; Kowala et al., 1994). Additionally, renin inhibition and angiotensin receptor blockers reduced atherosclerotic lesion size in cholesterol fed mice susceptible for atherosclerosis (Daugherty et al., 2004; Lu et al., 2007, 2008; Nussberger et al., 2008).

    • Angiotensin converting enzyme (ACE) inhibitory, antihypertensive and antihyperlipidaemic activities of protein hydrolysates from Rhopilema esculentum

      2012, Food Chemistry
      Citation Excerpt :

      Epidemiological and experimental studies have shown that ACE inhibitors had a beneficial effect in early atherosclerosis in addition to their antihypertensive activity (Chobanian, Haudenschild, Nickerson, & Drago, 1990; Fennessy, Campbell, & Campbell, 1994). Pharmacological studies have also demonstrated that ACE inhibitors could reduce plasma cholesterol in different animal models (Kowala, Grove, & Aberg, 1994; Sugano, Makino, & Yanaga, 1996). More recent studies have reported that protein hydrolysates from several food materials, such as sardinelle (Khaled et al., 2012), fish (Wergedahl, Gudbrandsen, Røst, & Berge, 2009), sesame (Biswas, Dhar, & Ghosh, 2010) and soy (Aoyama, Fukui, Takamatsu, Hashimoto, & Yamamoto, 2000; Zhong, Zhang, Ma, & Shoemaker, 2007) could affect plasma cholesterol concentrations and metabolisms of polyunsaturated fatty acids.

    • Vascular wall ACE is not required for atherogenesis in ApoE<sup>-/-</sup> mice

      2010, Atherosclerosis
      Citation Excerpt :

      It is well established that the renin angiotensin system is critically involved in the pathogenesis of atherosclerosis [6,8,20,21]. Studies in several different atherosclerotic models show that treatment with ACE inhibitors and angiotensin receptor blockers almost uniformly inhibit the formation of atherosclerotic lesions [6,22–30]. Wassman et al. [31] also showed that when AT1 receptor-deficient mice were crossed with apoE−/− mice, atherosclerotic lesion formation was reduced.

    View all citing articles on Scopus
    View full text